Increased risk of cardiac conduction abnormalities with ribociclib in patients with metastatic breast cancer: A combined analysis of phase III randomized controlled trials
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Hematology/Oncology and Stem Cell Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387620300479 |